Aquaculture and the production of pharmaceuticals and nutraceuticals

New Technologies in Aquaculture: Improving Production Efficiency, Quality and Environmental Management

Volumn , Issue , 2009, Pages 866-891

  Benkendorff, K ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84902571535     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1533/9781845696474.5.866     Document Type: Chapter

References (79)

1. Abdo D.A., Fromont J., Mcdonald J.I. Strategies, patterns and environmental cues for reproduction in two temperate haliclonid sponges. Aquat Biol 2008, 1:291-392.
2. Adis International Limited Trabectedin: Ecteinascidin 743, Ecteinascidin-743, ET 743, ET-743, NSC 684766. Drugs in R& 2006, 7:317-328.
3. Andlauer W., Fürst Nutraceuticals: a piece of history, present status and outlook. Food Res Int 2002, 35:171-176.
4. Apt K., Behrens P. Commercial developments in microalgal biotechnology. J Phycol 1999, 55:215-226.
5. Aroma New Zealand L.T.D. Company Profile and Product Specification 2007, Aroma New Zealand, Christchurch. http://www.aromanz.com.
6. Baker J.T., Duke C.C. Isolation of choline and choline ester salts of tyrindoxyl sulphate from the marine molluscs, Dicathais orbita and Mancinella keineri. Tetrahedron Letts 1976, 15:1233-1234.
7. Bansemir A., Blume M., SchrÖDer S., Lindequist U. Screening of cultivated seaweeds for antibacterial activity against fish pathogenic bacteria. Aquaculture 2006, 252:79-84.
8. Marine Nutraceuticals and Functional Foods 2007, CRC Press, Boca Raton, FL. C.J. Barrow, F. Shahidi (Eds.).
9. Benkendorff K., Mciver C.M., Westley C.B., Abbott C.A. NZMSS &AMSA Conference Abstracts. Anticancer complementary medicines from muricid molluscs 2008, University of Canterbury, Christchurch.
10. Benkendorff K., Mciver C.M., Abbott C.A. Bioactivity of the Murex homeopathic remedy and of extracts from an Australian muricid mollusc against human cancer cells. Evid-Based Compl Alt Med, In press (accepted April 2009) 2009.
11. Blunt J.W., Copp B.R., Munro M.H.G., Northcote P.T., Prinsep M.R. Marine natural products. Nat Prod Rep 2006, 23:26-78.
12. Blunt J.W., Copp B.R., Hu W.-P., Munro M.H.G., Northcote P.T., Prinsep M.R. Marine natural products. Nat Prod Rep 2007, 24:31-86.
13. Blunt J.W., Copp B.R., Hu W.-P., Munro M.H.G., Northcote P.T., Prinsep M.R. Marine natural products. Nat Prod Rep 2008, 25:35-94.
14. Boericke W. Homeopathic Materia Medica. Murex 1999, Winhomeo Book. 9th edn. W. Boericke (Ed.).
15. Borsig L., Wang L., Cavalcante M.C., Cardilo-Reis L., Ferreira P.L., Mourao P.A., Esko J.D., Pavao M.S. Selectin blocking activity of a fucosylated chondroitin sulfate glycosaminoglycan from sea cucumber. Effect on tumor metastasis and neutrophil recruitment. J Biol Chem 2007, 282:14984-14991.
16. Brower V. A nutraceutical a day may keep the doctor away. EMBO reports 2005, 6:708-711.
17. Butler M.S. Natural products to drugs: natural product-derived compounds in clinical trials. Nat Prod Rep 2008, 25:475-516.
18. Carmona R., Kraemer G., Yarish C. Exploring northeast American and Asian species of Porphyra for use in an intergrated finfish-algal aquaculture system. Aquaculture 2006, 252:54-65.
19. Cazalet S. Materia Medica: Repertorium Homepathicum (Reversed Kent's Repertory), Homeopathe International accessed January 2009. http://www.homeoint.org/hidb/kent/index.htm.
20. Chopin T. The Seaweed and Integrated Multi-Trophic Aquaculture (IMTA) Research Laboratory of Dr Thierry Chopin, University of New Brunswick accessed January 2009. http://www.unbsj.ca/sase/biology/chopinlab/.
21. Cobb C., Ernst E. Systematic review of a marine nutraceutical in clinical trials for arthritis: the effectiveness of the New Zealand green-lipped mussel Perna canaliculus. Clin Rheumatol 2006, 25:275-284.
22. De Caralt S., Agell G., Uriz M. Long-term culture of sponge explants: conditions enhancing survival and growth, and assessment of bioactivity. Biomol Eng 2003, 20:339-347.
23. Duckworth A. Farming sponges for chemicals with pharmaceutical potential. World Aquac 2001, 14-18.
24. Duckworth A., Battershill C., Bergquist P. Influence of explant procedures and environmental factors on culture success of three sponges. Aquaculture 1997, 156:251-267.
25. Emelyanov A., Fedoseev G., Kranoschekova O., Abulimity A., Trendeleva T., Barnes P.J. Treatment of asthma with lipid extract of New Zealand green-lipped mussel: A randomized clinical trial. Eur Respir J 2002, 20:596-600.
26. Eriksen N. Production of phycocyanin - a pigment with applications in biology, biotechnology, foods and medicine. Appl Microbiol Biotechnol 2008, 80:1-14.
27. Ettinger-Epstein P., Tapiolas D.M., Motti C.A., Wright A.D., Battershill C.N., De Nys R. Production of manoalide and its analogues by the sponge Luffariella variabilis is hardwired. Mar Biotechnol 2007, 10:64-74.
28. Faulkner D. Marine Pharmacology. Antonie van Leeuwenhoek 2000, 77:135-145.
29. Fenical W., Jensen P., Kauffman C., Mayhead S., Faulkner D., Sincich C., Rao M., Kantorowski E., West L., Strangman W., Shimizu Y., Li B., Thammana S., Drainville K., Davies-Coleman M., Kramer R., Fairchild C., Rose W., Wild R., Vite G., Peterson R. New anticancer drugs from cultured and collected marine organisms. Pharm Biol 2003, 41:6-14.
30. Fishlock D., Williams R.M. Synthetic studies on ET-743. Assembly of the pentacyclic core and a formal total synthesis. J Org Chem 2008, 73:9594-9600.
31. Gibson S.L.M. The effect of a lipid extract of the New Zealand green-lipped mussel in three cases of arthritis. J Alt Comp Med 2000, 6:351-354.
32. Halpern G.M. Anti-inflammatory effects of a stabilized lipid extract of Perna canaliculus (Lyprinol). Allerg Immunol 2000, 32:272-278.
33. Heckrodt T.J., Mulzer J. Marine natural products from Pseudopterogorgia elisabethae: Structure, biosynthesis, pharmacology and total synthesis. Topics in Current Chemistry: Natural Products Synthesis II 2005, 244:1-41.
34. Adams F. Hippocrates (460-377 BC) On ancient medicine, Trans 1849.
35. Higuera-Ciapara I., FéLix-Valenzuela L., Goycoolea F.M. Astaxanthin: A review of its chemistry and application. Crit Rev Food Sci 2006, 46:185-196.
36. Jimeno J., Faircloth G., Sousa-Faro J., Scheuer P., Rinehart K. New marine derived anticancer therapeutics - a journey from the sea to clinical trials. Mar Drugs 2004, 2:14-29.
37. Kang K.H., Kwon J.Y., Kim Y.M. A beneficial coculture: charm abalone Haliotis discus hannai and sea cucumber Stichopus japonicus. Aquaculture 2003, 216:87-93.
38. Kijjoa A., Sawangwong P. Drugs and cosmetics from the sea. Mar Drugs 2004, 2:73-82.
39. Koopman M., Wijffels R. Seasonal growth rate of the sponge Haliclona oculata (Demospongiae: Haplosclerida). Mar Biotechnol 2008, 10:502-510.
40. Lebeau T., Robert J. Diatom cultivation and biotechnologically relevant products. Part II: current and putative products. Appl Microbiol Biotechnol 2003, 60:624-632.
41. Lee Y. Microalgal mass culture systems and methods: their limitation and potential. J Appl Phycol 2001, 13:307-315.
42. Li Z., Wang H., Li J., Zhang G., Gao C. Basic and clinical study on the antithrombotic mechanism of glycosaminoglycan extracted from sea cucumber. Chin Med J 2000, 113:706-711.
43. Liu B.S., Yi Y.H., Li L., Zhang S.L., Han H., Weng Y.Y., Pan M.X. Arguside A: a new cytotoxic triterpene glycoside from the sea cucumber Bohadschia argus Jaeger. Chem Biodivers 2007, 4:2845-2851.
44. Lorenz T., Cysewski Commercial potential for Haematococcus microalgae as a natural source of astaxanthin. Trends Biotechnol 2000, 18:160-167.
45. Mackenzie C.L. Growth and reproduction of the oyster drill Eupleura caudate in the York River, Virginia. Ecology 1961, 42:317-338.
46. Magiatis P., Skaltsounis A.L. Indirubin, the Red Shade of Indigo. From Hexaples trunculus to new kinase inhibitory indirubins 2006, 147-156. Life in Progress Editions, Roscoff. L. Meijer, N. Guyard, L. Skaltsounis, G. Eisenbrand (Eds.).
47. Mata L., Silva J., Schuenhoff A., Santos R. The effects of light and temperature on the photosynthesis of the Asparagopsis armata tetrasporophyte (Falkenbergia rufolanosa), cultivated in tanks. Aquaculture 2006, 252:12-19.
48. Mcfarlane S.J., Croft J.E. Pharmaceutical preparations with gastro-protective action. Patent No. US4455298, accessed online esp@cenet database 20/02/2001 1984.
49. Mciver C., Abbott C., Benkendorff K. In vitro evaluation of bioactive muricid extracts and the murex homeopathic remedy in human solid tumors 2007, Adelaide, SA.
50. Meijer L., Skaltsounis A., Magiatis P., Polychronopoulos P., Knockaert M., Leost M., Ryan X., Vonica C., Brivanlou A., Dajani R., Crovace C., Tarricone C., Musacchio A., Roe S., Pearl L., Greengard P. GSK-3-Selective inhibitors derived from tyrian purple indirubins. Chem Biol 2003, 10:1255-1266.
51. Mendola D. Aquaculture of three phyla of marine invertebrates to yield bioactive metabolites: process developments and economics. Biomol Eng 2003, 20:441-458.
52. Molyneaux M., Lee C.M. The U.S. market for marine nutraceutical products. Food Technol 1998, 52:56-57.
53. Munro M., Blunt J., Dumdei E., Hickford S., Lill R., Li S., Battershill C., Duckworth A. The discovery and development of marine compounds with pharmaceutical potential. J Biotechnol 1999, 70:15-25.
54. Neori A., Chopin T., Troell M., Buschmann A.H., Kraemer G.P., Halling C., Shpigel M., Yarish C. Integrated aquaculture: rationale, evolution and state of the art emphasizing seaweed biofiltration in modern mariculture. Aquaculture 2004, 231:361-391.
55. Noble W. Molluscs 2006 Molluscs in Research, Conservation and the Economy. Breeding and larval ecology of Dicathais orbita, a potential novel aquaculture resource 2006, University of Wollongong, Triennial meeting of the Malcological Society of Australasia, 6-8 December.
56. Obatolu V.A., Skonberg D.I., Camire M.E., Dougherty M.P. Effect of moisture content and screw speed on the physical chemical properties of an extruded crab-based snack. Food Sci Technol Int 2005, 11:121-127.
57. Ohshima T. Recovery and use of nutraceutical products from marine resources. Aquaculture 1998, 231:361-391.
58. Page M.J., Northcote P.T., Webb V.L., Mackey S., Handley S.J. Aquaculture trials for the production of biologically active metabolities in the New Zealand sponge Mycale hentscheli (Demospongia: Poecilosclerida). Aquaculture 2005, 250:256-269.
59. Paltzat D.L., Pearce C.M., Barnes P.A., Mckinley R.S. Growth and production of California sea cucumbers (Parastichopus californicus Stimpson) co-cultured with suspended Pacific oysters (Crassostrea gigas Thunberg). Aquaculture 2008, 275:124-137.
60. Proksch P., Edrada-Ebel R., Ebel R. Drugs from the sea - opportunities and obstacles. Mar Drugs 2003, 1:5-17.
61. Rainsford K.D., Whitehouse M.W. Gastroprotective and anti-inflammatory properties of green lipped mussel (Perna canaliculus) preparation. Arzneim-Forsch 1980, 30:2128-2132.
62. Roseghini M., Severini C., Falconieri E., Erspamer V. Choline esters and biogenic amines in the hypobranchial gland of 55 molluscan species of the neogastropod Muricidae superfamily (Review). Toxicon 1996, 34:33-55.
63. Ruggieri G.D. Drugs from the sea. Science 1976, 194:491-497.
64. Sankaran J.K. Innovation and value-chains of nutraceuticals: The case of marine natural products, Department of Information Systems and Operations Management, University of Auckland, Auckland accessed January 2009. http://www.business.auckland.ac.nz/comwebContent/docs/(SF)Sankaran%20ANZAM%202006%20Conference%20Paper.pdf.
65. Sankaran J.K., Mouly V.S. Managing innovation in an emerging sector: The case of marine based nutraceuticals. R& Management 2007, 37:329-344.
66. Santos R. Special issue opening comments: seaweed-based intergrated mariculture. Aquaculture 2006, 252:1-2.
67. Sekar S., Chandramohan M. Phycobiliproteins as a commodity: trends in applied research, patents and commercialization. J Appl Phycol 2008, 20:113-136.
68. Sennett S.H. Marine Chemical Ecology. Marine chemical ecology: applications in marine biomedical prospecting 2001, 523-542. CRC Press, Boca Raton, FL. J.B. Mcclintock, B.J. Baker (Eds.).
69. Sipkema D., Osinga R., Schatton W., Mendola D., Tramper J., Wijffels R. Large-scale production of pharmaceuticals by marine sponges: sea, cell, or synthesis. Biotechnol Bioeng 2005, 90:201-222.
70. Smit A. Medicinal and pharmaceutical uses of seaweed natural products: a review. J Appl Phycol 2004, 16:245-262.
71. Straus S. Complementary and alternative medicine: Challenges and opportunities for pharmacology and therapeutic research. Pharmacologist 2000, 42:74-76.
72. Tenikoff D., Murphy K.M., Le M., Howe P., Howarth G.S. Lyprinol (stabilised lipid extract of New Zealand Green-Lipped mussel): a potential treatment modality for inflammatory bowel disease. J Gastroenterol 2005, 40:361-365.
73. Tapsell L., Williams P., Droulez V., Southee D., Patch C., Lethbridge A. Functional foods for the Australian industry: Definitions and opportunities 2005, National Centre of Excellence in Functional Foods, University of Wollongong. http://www.nceff.com.au/pdf/2005%20White%20Paper%20(final).pdf.
74. Van Treeck P., Eisinger M., MÜLler J., Paster M., Schuhmacher H. Mariculture trials with Mediterranean sponge species the exploitation of an old natural resource with sustainable and novel methods. Aquaculture 2003, 281:439-455.
75. Vine K., Locke J., Ranson M., Benkendorff K., Pyne S., Bremner J. In vitro cytotoxicity evaluation of some substituted isatin derivatives. Bioorg Med Chem 2007, 15:931-938.
76. Westley C., Vine K., Benkendorff K. Indirubin, the Red Shade of Indigo. A proposed functional role for indole derivatives in reproduction and defense of the Muricidae (Neogastropoda:Mollusca) 2006, 31-44. Life in Progress Editions, Roscoff. L. Meijer, N. Guyard, A.L. Skaltsounis, G. Eisenbrand (Eds.).
77. Whitehouse M.W., Butters D.E. Combination anti-inflammatory therapy: synergism in rats of NSAIDs/corticosteroids with some herbal/animal products. Inflammopharmacology 2003, 11:453-464.
78. Woodcock S.H., Benkendorff K. The impact of diet on the growth and proximate composition of juvenile whelks, Dicathais orbita (Gastropoda: Mollusca). Aquaculture 2008, 276:162-170.
79. Zhang S.Y., Yi Y.H., Tang H.F. Cytotoxic sulfated triterpene glycosides from the sea cucumber Pseudocolochirus violaceus. Chem Biodivers 2006, 3:807-817.